Assessing the biosimilarity of protein drugs: New study shows method's precision

First-ever interlaboratory study of four versions of a therapeutic protein drug -- all manufactured from living cells -- reports that an established analytical tool akin to magnetic resonance imaging reliably assessed the atomic structures of the biologically similar products, yielding the equivalent of a fingerprint for each.